Other Content - Pharmaceutical Executive

ADVERTISEMENT

Other Content

Challenges Developing an Aggregate Spend Database

September 27, 2013

George Mina, Pfizer's Director/TL-Data Strategy & Reconciliation-Transparency Medical Division - External Medical Communications, on the challenges of implementing the Physician Payment Sunshine Act for pharmaceutical companies

Lifecycle Solutions: Positioning Pharmaceuticals For Commercial Success

September 24, 2013

Addressing Industry Concerns Over PPSA

September 16, 2013

Dr. Shantanu Agrawal, director of data sharing & partnership group and the medical director for the center for program integrity at CMS on the Physician Payment Sunshine Act

3bl Media

August 18, 2013

3bl Media

What Makes an Emerging Pharma Leader

August 14, 2013

Editorial Director William Looney discusses the five essential characteristics exhibited by the more than 200 men and women selected by Pharmaceutical Executive as Emerging Pharma Leaders

Where Business Meets Policy

July 24, 2013

Publisher Russ Pratt on the Pharmaceutical Executive value proposition

Pharma PE Ebook

July 23, 2013

Pharma PE Ebook

Video: Flemming Ornskov on Shire Strategy

June 18, 2013

Along with the details of an ambitious new organization restructuring and strategic product plan, Shire CEO Flemming Ornskov emphasizes talks about the importance of alignment with the customer and the untapped potential from Shire’s expertise in that sweet spot in specialty – rare diseases.

Video: Pharma 50

June 11, 2013

In its 16th year, the Pharma 50 provides a unique window on the pace of industry change, with a focus on global, not just US revenues, and on revenues specifically from pharmaceuticals: patented, branded and generics. This approach gives a fuller, more rounded insight that tracks where the industry is heading ? and how well the science that drives progress in medicine is performing.

ADVERTISEMENT

Click here